Article
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.
American journal of hematology - 1 May 2025
Senapati Jayastu, Loghavi Sanam, Marvin-Peek Jennifer, Garcia-Manero Guillermo, Kadia Tapan M, Borthakur Gautam, Daver Naval, Short Nicholas J, Jain Nitin, Issa Ghayas C, Haddad Fadi, Hammond Danielle, Chien Kelly, Tang Guillin, Thakral Beenu, Montalban-Bravo Guillermo, Pemmaraju Naveen, Bazinet Alexandre, Swaminathan Mahesh, Pierce Sherry, Abbas Hussein A, Reville Patrick, Popat Uday, Shpall Elizabeth, Champlin Richard, Jabbour Elias, Ravandi Farhad, Kantarjian Hagop M, DiNardo Courtney D
Abstract excerpt
Ontogeny of acute myeloid leukemia (AML) provides prognostic information, however closer interrogation with respect to AML characteristics, genomics, and various treatments are warranted. We defined untreated clinical secondary (CS) AML as AML with a diagnosis of antecedent myelodysplastic syndrome (MDS) or MDS/myeloproliferative neoplasm (MDS-MPN) without exposure to hypomethylating agents or chemotherapy;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
